ACL vs CYC

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

44LOW

CYC

CYCLOPHARM FPO [CYC]

44LOW

Score Breakdown

ACL CYC
Technical
65
65
Catalyst
50
55
Sentiment
50
50
Fundamental
73
55
Momentum
37
39
Risk Gate
36
50

Key Metrics

ACL Metric CYC
$372.1MMarket Cap$91.8M
626KAvg Volume (20d)98K
+6.1%Short Interest+0.0%
$3.24052-Week High$1.475
$1.91552-Week Low$0.560
+2.8%Daily Change+6.7%
$2.010Entry Price$0.800
+16.7%ROE-49.3%
+3.6%Profit Margin-53.3%

Active Signals

ACL Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)

CYC Signals

●MACD momentum is picking up steam
●Above-average volume (1.7x) on a green day — buyers stepping up
●On a tear — up 11.1% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (2.8x)
●Moderate revenue growth (+18%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ACL and CYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ACL Full Analysis → CYC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).